Although some have speculated that #psychedelics produce enduring enhancements of cognitive flexibility, here we finally show that psilocybin therapy enhances cognitive and neural flexibility in major depressive disorder. However, there's a caveat. 1/10 nature.com/articles/s4139…
As previously reported, depression was reduced (doi.org/10.1001/jamaps…; see variability in single subject data provided here), but also cognitive flexibility (measured as a 𝑑𝑒𝑐𝑟𝑒𝑎𝑠𝑒 in perseverative errors) was enhanced 1 week post-psilocybin therapy. 2/10
Similar to reductions in PCC glutamate 1 day post-ayahuasca (doi.org/10.1093%2Fijnp…) ACC glutamate was reduced 1 week post-psilocybin. We didn't see increased (static) functional connectivity between ACC and PCC but ACC-PCC dynamics of FC (neural flexibility) was increased. 3/10
This is where it starts to get weird. Changes in cognitive and neural flexibility were correlated, but the association was +. That is, the greater the increases in ACC-PCC dynamics, the greater the increases in perseverative errors (i.e., 𝑙𝑒𝑠𝑠 cognitive flexibility). 4/10
To get a better idea of what was going on, I trained a set of predictive models (s/o @monicarosenb). Similar to prior work, baseline (pre-psilocybin) neural flexibility (dynamics of functional connectivity, dFC) was good at predicting baseline cognitive flexibility. 5/10
Also consistent with prior work, of the predictive features (dFC edges) selected in these models, greater neural flexibility was associated with greater cognitive flexibility (i.e., the greater the dynamics, the less the perseverative errors). 6/10
From baseline FC, we could also predict 𝑐ℎ𝑎𝑛𝑔𝑒𝑠 in cognitive flexibility using dynamics. However, we also needed static FC, and the best performing model only required the ACC (a structure important to psychedelic effects and cognitive flexibility). 7/10
But the relationship between predictive features (dFC edges, specifically) and cognitive flexibility was completely flipped! That is, greater baseline neural flexibility was associated with 𝑙𝑒𝑠𝑠 improvements in cognitive flexibility. 8/10
What could be happening here? Perhaps an inverted U. Some neural flexibility might be needed to get out of a depressive rut (e.g., during psychotherapy), but too much neural flexibility might be less beneficial (e.g., not be great for attention, doi.org/10.1016%2Fj.ne…). 9/10
Much 💜 to @monicarosenb, @n_sepeda, @p_fi, @jimpekar, everyone not on Twitter, and especially @FredBarrettPhD for letting me do whatever I wanted to with these datasets. We could have salami sliced the hell out of these data, but together, they tell a much clearer story. 10/10
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A short thread on DMT exceptionalism inspired by
this recent paper nature.com/articles/s4139…
There's a lot of folklore about DMT. It's potent, evokes "entity encounters," & produces no tolerance. I'm not convinced that DMT is a special case of psychedelic in any of these areas. 1/7
Moreover, 50 mg oral DMT w/a MAOI to prevent its breakdown (pharmahuasca) is a standard trip, but this would be an insane dose of oral psilocybin. For reference, the high doses of psilocybin in clin trials are 25-30 mg, & a rule of thumb is this dose is ~5 g dried mushrooms. 3/7
A review on psychoactive drugs & emotional episodic memory I started at the end of my PhD (better later than never...) Drugs & memory are typically studied in terms of conditioning/habit learning, but initial conscious experiences under drugs...
...may also play a role in future drug (ab)use. Episodic memory may be a bridge between early drug use & addiction. Alterations in emotional episodic memory may also be involved in the therapeutic efficacy of certain drugs currently under investigation (e.g., psychedelics).
2/21
Many times, someone will say "drug X impairs memory," but it's unclear whether drug X impairs the formation of memories (encoding), the stabilization of memories (consolidation), or the accessing/remembering of memories (retrieval). In a standard emotional memory task...
3/21
Immediate-onset but not delayed-onset PTSD associated with hallucinogen use: onlinelibrary.wiley.com/doi/10.1002/jt…
Assuming this effect is reliable, if it were simply self-medication, one has to wonder why those that develop PTSD later are not also using hallucinogens. 1/4
One possibility is that using hallucinogens while a traumatic event is still fresh and one is still sensitive to this trauma could increase the likelihood of developing PTSD. Many psychedelic users do tend to avoid using psychedelics soon after something traumatic happened. 2/4
Another possibility is that recent hallucinogen use could make one more sensitive and if trauma occurs within this "plasticity" window they could be more prone to developing PTSD. Easier said than done, but it'd suggest avoiding something bad happening shortly after tripping. 3/4
Not sure who needs to hear this :coughReviewer2cough: but a drug effect is not strictly on consolidation unless the drug is administered AFTER encoding. A 🧵 for how to enhance your memory w/alcohol, how to get false memories w/THC, & how psychopharmacology gets this wrong. 1/10
Giving a drug before encoding impacts encoding. If the effect only shows up after a delay between encoding and retrieval (≥24 hours), the drug's effect is still on encoding, but it's dependent on a period of consolidation (w/o the drug necessarily impacting consolidation). 2/11
For example, stimulants administered before encoding tend to enhance memory better when there is a delay between encoding and retrieval, and researchers have referred to this as a consolidation effect (link.springer.com/article/10.100…). WRONG! 3/11
In my talk on Monday, I discussed how psychedelics probably evoke 𝑝𝑟𝑒𝑠𝑞𝑢𝑒 𝑣𝑢/illusory insights, and these feelings of insight can be misattributed to ideas and mental imagery conjured up during a trip. I'm sure some people disagree with me, but consider this... 1/5
Last week, a paper came out showing that semantic priming can evoke illusory insights (under sober conditions). 2/5 link.springer.com/article/10.375…
Yesterday, a paper came out showing that feelings of insight can be misattributed to irrelevant ideas (under sober conditions). 3/5 nature.com/articles/s4159…
First real microdosing study reveals that low doses of #LSD increase estimation of time intervals: link.springer.com/article/10.100…
The authors refer to to this as "temporal dilation." However, similar to drug studies in episodic memory, there's an encoding vs. retrieval problem here. 1/n
If participants encode the initial interval in a temporally dilated state (time is perceived to be longer), then their reproductions will be longer. However, if the passage of time feels longer during reproduction, then shorter intervals should be reproduced. 2/n
For example, let's pretend you thought to yourself that an initial interval felt like 3 seconds (and it actually was). When you're reproducing it under a state in which time feels twice as long, you would think that 3 seconds passed when actually only 1.5 seconds had passed. 3/n